Long-term behavioral symptom clusters among survivors of early-stage breast cancer: Development and validation of a predictive model
- 9 September 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 117 (1) , 89-102
Abstract
Background: Fatigue, cognitive impairment, anxiety, depression, and sleep disturbance are cancer-related behavioral symptoms that may persist years after early-stage breast cancer, affecting quality of life. We aimed to generate a predictive model of long-term cancer-related behavioral symptoms clusters among breast cancer survivors 4 years after diagnosis. Methods: Patients with early-stage breast cancer were included from the CANcer TOxicity trial (ClinicalTrials.gov identifier NCT01993498). Our outcome was the proportion of patients reporting cancer-related behavioral symptoms clusters 4 years after diagnosis (≥3 severe symptoms). Predictors, including clinical, behavioral, and treatment-related characteristics; Behavioral Symptoms Score (BSS; 1 point per severe cancer-related behavioral symptom at diagnosis); and a proinflammatory cytokine (interleukin 1b; interleukin 6; tumor necrosis factor α) genetic risk score were tested using multivariable logistic regression, implementing bootstrapped augmented backwards elimination. A 2-sided P less than .05 defined statistical significance. Results: In the development cohort (n = 3555), 642 patients (19.1%) reported a cluster of cancer-related behavioral symptoms at diagnosis, and 755 (21.2%) did so 4 years after diagnosis. Younger age (adjusted odds ratio for 1-year decrement = 1.012, 95% confidence interval [CI] = 1.003 to 1.020), previous psychiatric disorders (adjusted odds ratio vs no = 1.27, 95% CI = 1.01 to 1.60), and BSS (adjusted odds ratio ranged from 2.17 [95% CI = 1.66 to 2.85] for BSS = 1 vs 0 to 12.3 [95% CI = 7.33 to 20.87] for BSS = 5 vs 0) were predictors of reporting a cluster of cancer-related behavioral symptoms (area under the curve = 0.73, 95% CI = 0.71 to 0.75). Genetic risk score was not predictive of these symptoms. Results were confirmed in the validation cohort (n = 1533). Conclusion: Younger patients with previous psychiatric disorders and higher baseline symptom burden have greater risk of long-term clusters of cancer-related behavioral symptoms. Our model might be implemented in clinical pathways to improve management and test the effectiveness of risk-mitigation interventions among breast cancer survivors.Keywords
Funding Information
- American Society of Clinical Oncology
- Rising Tide Foundation for Clinical Cancer Research
- Foundation ARC (ARCPGA2022010004401_4882)
- Breast Cancer Foundation Research
- Career Catalyst Research (CCR17483507)
- Foundation Gustave Roussy
- National Research Agency (ANR-10-COHO-0004, ANR-18-IBHU-0002)
- MYPROBE (ANR-17-RHUS-008)
- AstraZeneca
This publication has 73 references indexed in Scilit:
- Cancer‐related fatigue: Towards a more targeted approach based on classification by biomarkers and psychological factorsInternational Journal of Cancer, 2023
- Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast CancerJAMA Network Open, 2023
- Characterization of Depressive Symptoms Trajectories After Breast Cancer Diagnosis in Women in FranceJAMA Network Open, 2022
- Symptom clusters experienced by breast cancer patients at various treatment stages: A systematic reviewCancer Medicine, 2021
- Prevalence and severity of long‐term physical, emotional, and cognitive fatigue across 15 different cancer entitiesCancer Medicine, 2020
- The role of neuro‐immune interactions in cancer‐related fatigue: Biobehavioral risk factors and mechanismsCancer, 2019
- Determinants of physical, affective, and cognitive fatigue during breast cancer therapy and 12 months follow‐upInternational Journal of Cancer, 2017
- Personalised care planning for adults with chronic or long-term health conditionsCochrane Database of Systematic Reviews, 2015
- Patterns of psychiatric medication use among nationally representative long‐term cancer survivors and controlsCancer, 2014
- Pre‐treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapyPsycho-Oncology, 2008